TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Policy to Practice: Statewide Rollout of YMCA Childhood Obesity Standards
Brief Summary: The investigators long term-goal is to help YMCA programs across the nation successfully acheive the Y of USA "Healthy Eating and Physical Activity Standards". Our objective here is threefold. First, the investigators will work with South Carolina YMCA leadership to achieve the "Healthy Eating and Physical Activity Standards" and implement our HEPA Strategies in YMCA programs across the state, evaluate the uptake of and adherence to the standards and strategies, and identify factors that influence their implementation. Second, the investigators will evaluate the impact of acheiving the standards on children's MVPA and the serving and consumption of FV and water during the programs. Third, the investigators will evaluate the costs associated with and the cost-effectiveness of meeting the standards in terms of improvements in activity and healthy eating.


Options:
A: Arm Label: After school sports; Type: EXPERIMENTAL; Interventions: Behavioral: After school sports program | Arm Label: After school health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: After school health education | Intervention Type: BEHAVIORAL; Name: After school sports program; Assigned to Arm(s): After school sports | Intervention Type: BEHAVIORAL; Name: After school health education; Assigned to Arm(s): After school health education
B: Arm Label: Intervention; Type: OTHER; Interventions: Behavioral: Healthy Eating and Physical Activity | Intervention Type: BEHAVIORAL; Name: Healthy Eating and Physical Activity; Assigned to Arm(s): Intervention
C: Intervention Type: BEHAVIORAL; Name: Beat Osteoporosis: Nourish and Exercise Skeletons (BONES) Project; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Acute Medical Admission of ELDERly Patients (≥75yrs) to Either Fast Track or Traditional Inward Hospitalisation. A Randomised Controlled Trial
Brief Summary: To evaluate differences in health outcomes among elderly patients (age ≥ 75 years) treated in a Quick Diagnostic Unit (QDU) compared to the Department of Internal Medicine (DIM). A QDU is a medical Short Stay Unit (SSU).


Options:
A: Arm Label: Emergency Department (ED) Observation unit; Type: EXPERIMENTAL; Interventions: Other: Observation unit care, coupled with cardiac MRI | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Observation unit care, coupled with cardiac MRI; Assigned to Arm(s): Emergency Department (ED) Observation unit
B: Arm Label: QDU; Type: EXPERIMENTAL; Interventions: Other: QDU | Arm Label: DIM; Type: ACTIVE_COMPARATOR; Interventions: Other: DIM | Intervention Type: OTHER; Name: QDU; Assigned to Arm(s): QDU | Intervention Type: OTHER; Name: DIM; Assigned to Arm(s): DIM
C: Arm Label: Inpatient Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CDU-CMR Protocol; Type: EXPERIMENTAL; Interventions: Other: Clinical decision unit care, coupled with cardiac MRI | Intervention Type: OTHER; Name: Clinical decision unit care, coupled with cardiac MRI; Assigned to Arm(s): CDU-CMR Protocol
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: OU - Cardiac MRI | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: OU - Conventional Care Testing | Intervention Type: OTHER; Name: OU - Cardiac MRI; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: OU - Conventional Care Testing; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mediterranean Diet: A New Nutritional Approach for the Treatment of Normal Weight Women With Polycystic Ovary Syndrome (PCOS)?
Brief Summary: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women characterized by chronic anovulation, hyperandrogenism and insulin resistance. Available guidelines recommend lifestyle intervention although they do not suggest the best dietetic regimen for the treatment of PCOS. Thus, the purpose of this study is to compare the effectiveness of two nutritional protocols, namely Mediterranean Diet and standardized normocaloric Diet in normal weight women with PCOS.


Options:
A: Arm Label: Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Other: mediterranean diet | Arm Label: normocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Other: normocaloric diet | Intervention Type: OTHER; Name: mediterranean diet; Assigned to Arm(s): Mediterranean Diet | Intervention Type: OTHER; Name: normocaloric diet; Assigned to Arm(s): normocaloric diet
B: Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written dietary recommendations | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Behavioral: Cocinar Para Su Salud Program | Intervention Type: BEHAVIORAL; Name: Cocinar Para Su Salud Program; Assigned to Arm(s): Arm B | Intervention Type: BEHAVIORAL; Name: Written dietary recommendations; Assigned to Arm(s): Arm A
C: Arm Label: Intensive Portfolio; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dietary Portfolio - Intensive | Arm Label: Routine Portfolio; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dietary Portfolio - Routine | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Control (low saturated fat therapeutic diet) | Intervention Type: DIETARY_SUPPLEMENT; Name: Dietary Portfolio - Intensive; Assigned to Arm(s): Intensive Portfolio | Intervention Type: DIETARY_SUPPLEMENT; Name: Dietary Portfolio - Routine; Assigned to Arm(s): Routine Portfolio | Intervention Type: DIETARY_SUPPLEMENT; Name: Control (low saturated fat therapeutic diet); Assigned to Arm(s): Control
D: Arm Label: Diet: Dietary Advice; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: General Advice | Arm Label: Low glycemic index Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low Glycemic Index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Glycemic Index Mediterranean Diet; Assigned to Arm(s): Low glycemic index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: General Advice; Assigned to Arm(s): Diet: Dietary Advice

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I/II, Open-label, Uncontrolled, Single-dose, Dose-ascending, Multi-centre Trial Investigating an Adeno-associated Viral Vector Containing a Codon-optimized Human Factor IX Gene (AAV5-hFIX) Administered to Adult Patients With Severe or Moderately Severe Hemophilia B
Brief Summary: This study evaluates how safe gene therapy treatment with AAV5-hFIX is in adult patients with severe or moderately severe hemophilia B and severe bleeding type.


Options:
A: Arm Label: SPK-9001; Type: EXPERIMENTAL; Interventions: Biological: SPK-9001 | Intervention Type: BIOLOGICAL; Name: SPK-9001; Assigned to Arm(s): SPK-9001
B: Arm Label: Cohort 1; Type: EXPERIMENTAL; Interventions: Genetic: AAV5-hFIX | Arm Label: Cohort 2; Type: EXPERIMENTAL; Interventions: Genetic: AAV5-hFIX | Intervention Type: GENETIC; Name: AAV5-hFIX; Assigned to Arm(s): Cohort 1, Cohort 2
C: N/A
D: Arm Label: All participants; Type: EXPERIMENTAL; Interventions: Drug: BIIB031 (rFVIIIFc), Drug: FVIII (PK subgroup only) | Intervention Type: DRUG; Name: BIIB031 (rFVIIIFc); Assigned to Arm(s): All participants | Intervention Type: DRUG; Name: FVIII (PK subgroup only); Assigned to Arm(s): All participants

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Controlled, 2-arm Parallel Group, Multi-center Study, to Evaluate Biological and Functional Changes in Healthy Smokers Switching to Tobacco Heating System 2.2 (THS 2.2) Compared to Continuing Smoking Conventional Cigarettes for 26 Weeks in an Ambulatory Setting
Brief Summary: The aim of the study is to demonstrate clinical, biological and functional health changes in smokers switching to the candidate modified risk tobacco product: Tobacco Heating System 2.2 (THS 2.2) as compared to smokers continuing smoking their conventional cigarettes (CC) over a 26-week period.

To characterize the study as successful, at least 5 clinical risk endpoints should move in the direction of smoking cessation and these results would be statistically significant. The main analysis will be defined a priori (using the Hailperin-Ruger approach) and will be made between THS 2.2 use and CC use as "per actual product used" and product use categories.


Options:
A: Arm Label: THS 2.2; Type: EXPERIMENTAL; Interventions: Other: THS 2.2 | Arm Label: CC; Type: ACTIVE_COMPARATOR; Interventions: Other: CC | Intervention Type: OTHER; Name: THS 2.2; Assigned to Arm(s): THS 2.2 | Intervention Type: OTHER; Name: CC; Assigned to Arm(s): CC
B: Arm Label: THS 2.2 Menthol (mTHS 2.2); Type: EXPERIMENTAL; Interventions: Other: THS 2.2 Menthol (mTHS 2.2) | Arm Label: Menthol Conventional Cigarette (mCC); Type: ACTIVE_COMPARATOR; Interventions: Other: Menthol Conventional Cigarette (mCC) | Arm Label: Smoking abstinence (SA); Type: SHAM_COMPARATOR; Interventions: Other: Smoking Abstinence (SA) | Intervention Type: OTHER; Name: THS 2.2 Menthol (mTHS 2.2); Assigned to Arm(s): THS 2.2 Menthol (mTHS 2.2) | Intervention Type: OTHER; Name: Menthol Conventional Cigarette (mCC); Assigned to Arm(s): Menthol Conventional Cigarette (mCC) | Intervention Type: OTHER; Name: Smoking Abstinence (SA); Assigned to Arm(s): Smoking abstinence (SA)
C: Arm Label: IQOS; Type: EXPERIMENTAL; Interventions: Device: IQOS | Arm Label: E-CIG; Type: ACTIVE_COMPARATOR; Interventions: Device: E-CIG | Intervention Type: DEVICE; Name: IQOS; Assigned to Arm(s): IQOS | Intervention Type: DEVICE; Name: E-CIG; Assigned to Arm(s): E-CIG
D: Arm Label: CHTP 1.0; Type: EXPERIMENTAL; Interventions: Other: CHTP 1.0 | Arm Label: Conventional cigarette (CC); Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Cigarette (CC) | Intervention Type: OTHER; Name: CHTP 1.0; Assigned to Arm(s): CHTP 1.0 | Intervention Type: OTHER; Name: Conventional Cigarette (CC); Assigned to Arm(s): Conventional cigarette (CC)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Brief Summary: In partnership with a multi-site, Los Angeles-area community clinic consortium, North East Valley Health Corporation (NEVHC), the investigators will use telehealth to integrate pediatric developmental, behavioral and mental health (DB/MH) services into primary care for low-income, publicly insured children. During Project Year 1, the investigators used qualitative methods to conduct and analyze interviews with parents, clinicians, and staff at NEVHC to assess their perspectives on the delivery of child DB/MH services and on a potential telehealth-based patient visit, coordination, and clinician education system for the provision of DB/MH specialty care in primary care settings to children ages 5-12. This data was used in a stakeholder-engaged process to customize a telehealth-based delivery system for pediatric DB/MH services that can be integrated into primary care settings.

During Project Years 2-3, the investigators will conduct a cluster randomized controlled trial (RCT) to compare the customized telehealth-based patient visit, coordination, and clinician education system to the usual in-person, community- based referral system at NEVHC. This study will examine whether a telehealth developmental, behavioral and mental health delivery model can be an effective, efficient, and family-centered way to provide integrated DB/MH services to children in low-income communities.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Ninos Sanos Familia Sana | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ninos Sanos Familia Sana | Intervention Type: BEHAVIORAL; Name: Ninos Sanos Familia Sana; Assigned to Arm(s): Comparison, Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Practice Facilitation | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Practice Facilitation; Assigned to Arm(s): 1
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telehealth Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Telehealth Intervention | Intervention Type: BEHAVIORAL; Name: Telehealth Intervention; Assigned to Arm(s): Telehealth Intervention
D: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Systems-level intervention to promote colon cancer screening | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Systems-level intervention to promote colon cancer screening; Assigned to Arm(s): Interventional

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: miPlan: A Randomized Controlled Trial of miPlan Intervention vs. Standard of Care
Brief Summary: Using our experience in digital media, behavior theory, client-centered interventions, and family planning, we have prototyped a digital application ("app")-miPlan-to be used in the clinic waiting room prior to a contraceptive visit. The goal of this research is to refine the app and conduct a randomized controlled trial of the miPlan intervention vs. standard care. The aim of this study is to understand miPlan's impact. The primary outcome is LARC uptake at clinic discharge. The secondary outcomes are contraceptive use at discharge, self-efficacy and decisional balance for highly effective contraception post-app use, contraceptive satisfaction, and intention to continue method use. The research will consist of baseline activities as well as a three-month follow-up call.


Options:
A: Arm Label: Positive adjustment coping intervention; Type: EXPERIMENTAL; Interventions: Other: Positive adjustment coping intervention | Arm Label: Brainteaser; Type: OTHER; Interventions: Other: Brainteaser | Intervention Type: OTHER; Name: Positive adjustment coping intervention; Assigned to Arm(s): Positive adjustment coping intervention | Intervention Type: OTHER; Name: Brainteaser; Assigned to Arm(s): Brainteaser
B: Arm Label: Two-way SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Two-way SMS | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Two-way SMS; Assigned to Arm(s): Two-way SMS
C: Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Behavioral: Counseling | Arm Label: Automated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Other: Smartphone-delivered automated treatment | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Standard Treatment | Intervention Type: OTHER; Name: Smartphone-delivered automated treatment; Assigned to Arm(s): Automated Treatment
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: miPlan intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: miPlan intervention; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
Brief Summary: The purpose of this study is to evaluate the relative impact a medical drug (methadone) or behavioral counseling program (Holistic Health Recovery Program) or both (methadone and Holistic Health Recovery Program) has on reducing HIV-related risk behaviors and illicit drug use among opioid-dependent, HIV-infected individuals in prison when given 90 to 180 days prior to leaving prison.


Options:
A: Arm Label: Interim Buprenorphine Treatment; Type: EXPERIMENTAL; Interventions: Drug: Interim Buprenorphine Treatment (IBT) | Arm Label: Waitlist Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Interim Buprenorphine Treatment (IBT); Assigned to Arm(s): Interim Buprenorphine Treatment
B: Arm Label: Methadone Maintenance; Type: EXPERIMENTAL; Interventions: Drug: Methadone | Arm Label: Holistic Health Recovery Program; Type: EXPERIMENTAL; Interventions: Behavioral: Holistic Health Recovery Program | Arm Label: Methadone Maintenance and Holistic Health Recovery Prorgram; Type: EXPERIMENTAL; Interventions: Drug: Methadone, Behavioral: Holistic Health Recovery Program | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone Maintenance, Methadone Maintenance and Holistic Health Recovery Prorgram | Intervention Type: BEHAVIORAL; Name: Holistic Health Recovery Program; Assigned to Arm(s): Holistic Health Recovery Program, Methadone Maintenance and Holistic Health Recovery Prorgram
C: Arm Label: Naltrexone intramuscular suspension; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone intramuscular suspension | Arm Label: Buprenorphine-naloxone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Buprenorphine-naloxone | Intervention Type: DRUG; Name: Naltrexone intramuscular suspension; Assigned to Arm(s): Naltrexone intramuscular suspension | Intervention Type: DRUG; Name: Buprenorphine-naloxone; Assigned to Arm(s): Buprenorphine-naloxone
D: Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Active-controlled, Clinical Trial Comparing Effects of Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
Brief Summary: The purpose of the study was to determine whether mindfulness training could be more effective than another active intervention in reducing borderline personality disorder (BPD) symptoms. The main hypothesis was that patients allocated to the mindfulness group would show a greater improvement on global BPD symptomatology. As a second objective, we explored some of the possible underlying mechanisms of both active treatments. For that purpose, changes in decentering, mindfulness facets and cognitive processing of social interactions were also evaluated.


Options:
A: Arm Label: MBT therapy plus treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Mentalization-Based Group Therapy for Adolescents | Arm Label: Treatment as usual alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mentalization-Based Group Therapy for Adolescents; Assigned to Arm(s): MBT therapy plus treatment as usual
B: Arm Label: S-DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Standard dialectical behavior therapy (SDBT) | Arm Label: DBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual DBT with no DBT group sessions (DBT-I) | Arm Label: DBT-S; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group Skills DBT with no DBT individual sessions (DBT-S) | Intervention Type: BEHAVIORAL; Name: Standard dialectical behavior therapy (SDBT); Assigned to Arm(s): S-DBT | Intervention Type: BEHAVIORAL; Name: Individual DBT with no DBT group sessions (DBT-I); Assigned to Arm(s): DBT-I | Intervention Type: BEHAVIORAL; Name: Group Skills DBT with no DBT individual sessions (DBT-S); Assigned to Arm(s): DBT-S
C: Arm Label: Mindfulness; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness | Arm Label: Interpersonal effectiveness; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: interpersonal effectiveness | Intervention Type: BEHAVIORAL; Name: Mindfulness; Assigned to Arm(s): Mindfulness | Intervention Type: BEHAVIORAL; Name: interpersonal effectiveness; Assigned to Arm(s): Interpersonal effectiveness
D: Arm Label: NMDA receptor antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: NMDA receptor antagonist (active drug) | Arm Label: Placebo tablet; Type: PLACEBO_COMPARATOR; Interventions: Other: Lactose packed capsule (inert/inactive arm) | Intervention Type: DRUG; Name: NMDA receptor antagonist (active drug); Assigned to Arm(s): NMDA receptor antagonist | Intervention Type: OTHER; Name: Lactose packed capsule (inert/inactive arm); Assigned to Arm(s): Placebo tablet

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Active-controlled, Clinical Trial Comparing Effects of Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
Brief Summary: The purpose of the study was to determine whether mindfulness training could be more effective than another active intervention in reducing borderline personality disorder (BPD) symptoms. The main hypothesis was that patients allocated to the mindfulness group would show a greater improvement on global BPD symptomatology. As a second objective, we explored some of the possible underlying mechanisms of both active treatments. For that purpose, changes in decentering, mindfulness facets and cognitive processing of social interactions were also evaluated.


Options:
A: Arm Label: SB-APP Psychotherapy; Type: EXPERIMENTAL; Interventions: Other: SB-APP | Arm Label: TAU treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: treatment as usual | Intervention Type: OTHER; Name: SB-APP; Assigned to Arm(s): SB-APP Psychotherapy | Intervention Type: OTHER; Name: treatment as usual; Assigned to Arm(s): TAU treatment
B: Arm Label: VHS group; Type: EXPERIMENTAL; Interventions: Behavioral: the volitional help sheet | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: the volitional help sheet; Assigned to Arm(s): VHS group
C: Arm Label: Dialectical Behavior Therapy Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Behavioral: Dialectical Behavior Therapy | Arm Label: Dialectical Behavior Therapy placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical Behavior Therapy | Arm Label: Supportive therapy Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Behavioral: Supportive psychotherapy | Arm Label: Supportive therapy placebo; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supportive psychotherapy | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Dialectical Behavior Therapy Fluoxetine, Supportive therapy Fluoxetine | Intervention Type: BEHAVIORAL; Name: Dialectical Behavior Therapy; Assigned to Arm(s): Dialectical Behavior Therapy Fluoxetine, Dialectical Behavior Therapy placebo | Intervention Type: BEHAVIORAL; Name: Supportive psychotherapy; Assigned to Arm(s): Supportive therapy Fluoxetine, Supportive therapy placebo
D: Arm Label: Mindfulness; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness | Arm Label: Interpersonal effectiveness; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: interpersonal effectiveness | Intervention Type: BEHAVIORAL; Name: Mindfulness; Assigned to Arm(s): Mindfulness | Intervention Type: BEHAVIORAL; Name: interpersonal effectiveness; Assigned to Arm(s): Interpersonal effectiveness

Answer: D